Short Interest in Milestone Scientific Inc. (NYSE:MLSS) Increases By 42.5%

Milestone Scientific Inc. (NYSE:MLSS - Get Free Report) was the target of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 154,000 shares, an increase of 42.5% from the May 15th total of 108,100 shares. Based on an average daily volume of 67,100 shares, the days-to-cover ratio is presently 2.3 days. Currently, 0.3% of the shares of the company are sold short.

Insider Buying and Selling at Milestone Scientific

In related news, major shareholder S.R.L. Bp4 sold 60,200 shares of the firm's stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $0.90, for a total value of $54,180.00. Following the completion of the transaction, the insider now directly owns 9,531,402 shares of the company's stock, valued at approximately $8,578,261.80. This trade represents a 0.63% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders have sold a total of 128,469 shares of company stock valued at $116,948 over the last three months. 24.75% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Milestone Scientific

Institutional investors and hedge funds have recently modified their holdings of the company. XTX Topco Ltd grew its stake in Milestone Scientific by 99.2% during the first quarter. XTX Topco Ltd now owns 34,135 shares of the company's stock valued at $32,000 after acquiring an additional 17,002 shares in the last quarter. Brookwood Investment Group LLC bought a new position in Milestone Scientific in the 1st quarter valued at $46,000. Finally, Renaissance Technologies LLC grew its position in shares of Milestone Scientific by 72.8% during the 4th quarter. Renaissance Technologies LLC now owns 126,275 shares of the company's stock valued at $121,000 after purchasing an additional 53,198 shares in the last quarter. 5.79% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Wall Street Zen assumed coverage on Milestone Scientific in a research report on Sunday, May 18th. They set a "hold" rating on the stock.

Milestone Scientific Stock Performance

MLSS remained flat at $0.88 during trading on Monday. The company had a trading volume of 64,559 shares, compared to its average volume of 129,757. Milestone Scientific has a twelve month low of $0.58 and a twelve month high of $1.39. The company has a 50-day simple moving average of $0.94 and a 200-day simple moving average of $1.00. The stock has a market cap of $69.06 million, a P/E ratio of -12.57 and a beta of 0.90.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.